In vitro activity of dirithromycin against Chlamydia trachomatis.
Dirithromycin is a new macrolide antibiotic with an active metabolite, erythromycylamine. We evaluated the in vitro activities of both drugs against 16 isolates of Chlamydia trachomatis and compared them with that of doxycycline. In vitro susceptibility testing was performed with McCoy cell monolaye...
Enregistré dans:
| Publié dans: | Antimicrob Agents Chemother |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology (ASM)
1994
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284716/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7811051/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.9.2213 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|